Dear Contractor
SPPG issued correspondence on behalf of NICPLD on 9 February 2026 inviting feedback on the FTY 2026/2027 Selection and Admission process.

SUMMARY

  • NICPLD is seeking the views of all pharmacy organisations regarding the FTY Selection and Admission process used to select students for the 200 FTY training places available in NI.
  • Students who were successfully selected by the new process have now been matched with their FTY training places in hospital and community pharmacy settings, and will commence training in August 2026.
  • NICPLD would welcome feedback from pharmacy organisations regardless of whether they participated in the 2026/2027 process, and regardless of whether they were allocated a 2026/2027 Trainee pharmacist.
  • Feedback will be utilised to implement any necessary changes or improvements for the upcoming FTY 2027/2028 Selection and Admission process.
  • The feedback survey is available here and will remain open until 6 March 2026.

ACTION

Contractors may wish to note the information in the SPPG/NICPLD correspondence and share any relevant feedback by completing the survey before the closing date on 6 March 2026.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
REMINDER: LIVING WELL CAMPAIGN SURVEY
** FAO: ALL LIVING WELL PHARMACIES
INCLUDING

PARTICIPANTS IN TARGET BRIEF INTERVENTION SERVICE **
Dear Contractor
Correspondence has been issued by SPPG on 16 February 2026 to those pharmacies yet to submit an evaluation survey for the Living Well campaign 
How are you feeling‘.  The survey will close at 6pm on 2 March 2026.

SUMMARY

  • All pharmacies contracted to provide the Living Well service must complete an evaluation survey after each campaign, unless otherwise informed.
  • SPPG reserves the right to recoup payment for a campaign if the evaluation survey is not submitted.
  • The survey for the campaign ‘How are you feeling’ is open and can be accessed here.
  • The survey must be completed by 6pm Monday 2nd March 2026.  Please ensure to reach the final screen to confirm submission.

ACTION

  • Contractors who have yet to complete the Living Well survey for the campaign ‘How are you feeling’ are asked to read the correspondence, share with relevant team members, and ensure completion prior to 6pm on 2 March 2026.

For any further information please contact CPNI offices or speak to your local SPPG office.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The first update of concessionary prices were granted today for February 2026:
DrugPack SizeConcessionary Price
Amoxicillin 250mg/5ml oral suspension100£1.37
Aspirin 75mg dispersible tablets28£3.04
Aspirin 75mg dispersible tablets100£10.86
Betamethasone 500microgram soluble tablets sugar free100£47.89
Cimetidine 400mg tablets60£5.55
Clomipramine 50mg capsules28£6.99
Co-codamol 30mg/500mg capsules100£5.68
Cyclizine 50mg/1ml solution for injection ampoules5£3.41
Diclofenac sodium 50mg gastro-resistant tablets28£5.80
Ibandronic acid 150mg tablets1£18.40
Lymecycline 408mg capsules28£3.45
Lymecycline 408mg capsules56£6.90
Mometasone 0.1% cream100£12.18
Mometasone 0.1% cream30£3.99
Naftidrofuryl 100mg capsules84£10.58
Oxazepam 10mg tablets28£7.20
Propranolol 160mg modified-release capsules28£5.50
Sulpiride 200mg tablets30£5.71
Temazepam 10mg tablets28£24.19
Tibolone 2.5mg tablets28£4.30
Zolmitriptan 2.5mg orodispersible tablets sugar free6£3.97

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

The Recognition of Excellence (RoE) Awards Return, Championing the Work of Community Pharmacy

Entries for this year’s Recognition of Excellence Awards programme are now open and pharmacy teams are encouraged to nominate themselves or colleagues before the closing date 6 April 2026 here.

There are several award categories and further information is available here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive

Dear Colleague,

An urgent opportunity has arisen for CPNI representatives to brief the NI Assembly Committee for Health on Thursday 26th February 2026.  This is an important meeting at which CPNI representatives will update MLAs on Medicines Supply and Community Pharmacy Pressures.

CPNI has been warning of heightened risks to medicines supply and patient access due to ongoing UK-wide shortages and severe financial pressure on the community pharmacy sector in Northern Ireland, which is making the situation more acute here.

What We Are Asking Contractors to Do?

This meeting provides a public platform at which CPNI can brief the Health Committee and to strengthen this engagement, we are inviting contractors to get in touch with their local Health Committee MLAs and share their own experiences.  Given the limited timeframe, we are asking contractors to focus on the following specific actions:

1. Engage with Your Local Health Committee MLA

Please contact your local MLA by phone, email, or in-person over the next two weeks (contact details are listed below).  Fridays are constituency days and MLAs are often in their offices to take calls or meet with local constituents.

Key points to raise:

  • Pharmacies are a critical front-line service for patients, dispensing millions of prescriptions annually.  However current funding and supply chain pressures mean the sector’s ability to maintain reliable medicines access is increasingly under strain.
  • Where applicable, include references to any difficulties you have experienced in paying medicine wholesalers in recent months, if you anticipate this getting worse and any additional steps you have had to take to pay medicine bills.
  • With escalating medicines shortages, outline that you have growing concerns that patient care is being potentially compromised through delays, leading to increased clinical risk.
  • To illustrate the situation, provide examples of key medicine shortages you are increasingly dealing with and the conditions they treat.
  • Outline the significant time spent sourcing stock that is no longer readily available.

2. Patient Power

  • The patient voice is powerful and if you have any patients who would like to share their experiences of medicines shortages and how this has affected them, please do encourage them to also contact their local Health Committee representative.

3. Social Media

  • Take a screenshot of the list of shortages, including the lines you can’t secure at Drug Tariff price and share this on social media, tagging your local MLAs.
  • You could add in your own words that the Department of Health aren’t funding you properly to buy this/these medicines.

Why This Matters Now?

Without urgent stabilisation of the community pharmacy sector, medicines supply risks will increasingly affect patients, primary care services and the wider health system in Northern Ireland.

It is important that the Health Committee members are fully briefed and this can only happen if they hear directly from contractors ‘on the ground’ in their local constituencies.  This will significantly strengthen the case being presented and ensure that the risks to patient care are fully understood, in addition to supporting CPNI’s call for urgent departmental engagement to address the unsustainable funding model to protect and maintain safe, sustainable pharmacy services.

Health Committee Members

North Antrim:
Chairperson: Mr. Philip McGuigan MLA, Sinn Féin
Email: philip.mcguigan@mla.niassembly.gov.uk
Tel: 028 2765 7198

East Antrim:
Deputy Chairperson: Mr. Danny Donnelly MLA, Alliance
Email: danny.donnelly@co.niassembly.gov.uk
Tel: 028 2889 8005

North Down:
Mr. Alan Chambers MLA, UUP
Email: alan.chambers@co.niassembly.gov.uk
Tel: 028 9147 7555

Mid Ulster:
Mrs. Linda Dillon MLA, Sinn Féin
Email: linda.dillon@mla.niassembly.gov.uk
Tel: 028 8774 8689

Upper Bann:
Mrs. Diane Dodds MLA, DUP
Email: diane.dodds@mla.niassembly.gov.uk
Tel: 028 4052 0048

West Belfast:
Miss Órlaithí Flynn MLA, Sinn Féin                                      
Email: orlaithi.flynn@mla.niassembly.gov.uk
Tel: 028 9080 8404

North Belfast:
Miss Nuala McAllister MLA, Alliance
Email: nuala.mcallister@mla.niassembly.gov.uk
Tel: 028 9590 7201

South Down:
Mr. Colin McGrath MLA, SDLP South Down
Email: colin.mcgrath@mla.niassembly.gov.uk
Tel: 028 4379 8350

East Londonderry:
Mr. Alan Robinson MLA, DUP
Email: alan.robinson@mla.niassembly.gov.uk
Tel: 028 7776 9191

If there isn’t an MLA from your area represented on the Health Committee, please share your experiences with the Committee Chairperson and Deputy Chairperson.

This is a critical moment for community pharmacy and your engagement, will make a meaningful difference.

Thank you for your continued professionalism and commitment to patient care and please do get in touch with CPNI, if you need further information.

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor,
SPPG issued correspondence dated 6th February regarding the recall of some Danone Infant Formula products.  This is an addendum to HSS(MD) 03/2026 – Food Standards Agency (FSA) Alert: Nestlé recalls several SMA Infant Formula and Follow-On Formula which was issued by CPNI on Thursday 8th January 2026.

Summary

Action

Contractors should note the SPPG correspondence regarding the recall of certain Danone infant formula products and ensure this information is shared promptly with relevant members of the pharmacy team.

Any affected stock should be identified and managed in line with the guidance provided.

Should contractors have queries they may wish to contact their local SPPG primacy care office.

Kind regards,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive